DBV Technologies (DBVT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $9.05, -0.66% vs the prior close of $9.11.
- Volume 592.92K shares, 1.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DBVT dips 0.7% to $9.05. Closed at $9.05, -0.66% vs the prior close of $9.11. Day range $8.63–$9.13, opened at $9.02.
DBVT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — DBVT dips 0.7% to $9.05
- Closed at $9.05, -0.66% vs the prior close of $9.11. Day range $8.63–$9.13, opened at $9.02.
- Volume was 592.92K shares, 1.7x its 50-day average of 344.59K.
- Price is -27.1% vs its 50-day average ($12.41) and -47.8% vs its 200-day average ($17.34).
- 52-week range $8.63–$26.18; today's close sits at 2% of that range, 65.4% below the 52-week high.
Oct 15, 2026 — DBVT rises 2.7% to $9.11
- Closed at $9.11, +2.71% vs the prior close of $8.87. Day range $8.85–$9.20, opened at $8.87.
- Volume was 432.30K shares, 1.3x its 50-day average of 344.09K.
- Price is -27.1% vs its 50-day average ($12.50) and -47.6% vs its 200-day average ($17.39).
- 52-week range $8.85–$26.18; today's close sits at 1% of that range, 65.2% below the 52-week high.
Oct 14, 2026 — DBVT dips 1.8% to $8.87, a 52-week low, 3 down days in a row
- Closed at $8.87, -1.77% vs the prior close of $9.03. Day range $8.86–$9.11, opened at $9.09.
- Volume was 351.20K shares, 1.0x its 50-day average of 343.68K.
- Price is -29.6% vs its 50-day average ($12.61) and -49.2% vs its 200-day average ($17.45).
- 52-week range $8.86–$26.18; today's close sits at 0% of that range, 66.1% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — DBVT slides 5.4% to $9.03, a 52-week low
- Closed at $9.03, -5.45% vs the prior close of $9.55. Day range $8.90–$9.50, opened at $9.47.
- Volume was 344.10K shares, 1.0x its 50-day average of 342.89K.
- Price is -28.9% vs its 50-day average ($12.70) and -48.4% vs its 200-day average ($17.50).
- 52-week range $8.90–$26.18; today's close sits at 1% of that range, 65.5% below the 52-week high.
Oct 12, 2026 — DBVT dips 2.6% to $9.55
- Closed at $9.55, -2.55% vs the prior close of $9.80. Day range $9.39–$9.72, opened at $9.63.
- Volume was 311.80K shares, 0.9x its 50-day average of 343.69K.
- Price is -25.4% vs its 50-day average ($12.80) and -45.6% vs its 200-day average ($17.55).
- 52-week range $9.36–$26.18; today's close sits at 1% of that range, 63.5% below the 52-week high.
Oct 9, 2026 — DBVT rises 2.6% to $9.80
- Closed at $9.80, +2.62% vs the prior close of $9.55. Day range $9.43–$9.86, opened at $9.62.
- Volume was 324.00K shares, 0.9x its 50-day average of 350.38K.
- Price is -23.9% vs its 50-day average ($12.87) and -44.3% vs its 200-day average ($17.59).
- 52-week range $9.36–$26.18; today's close sits at 3% of that range, 62.6% below the 52-week high.
Oct 8, 2026 — DBVT dips 2.3% to $9.55, a 52-week low, 6 down days in a row
- Closed at $9.55, -2.25% vs the prior close of $9.77. Day range $9.36–$9.84, opened at $9.74.
- Volume was 603.30K shares, 1.7x its 50-day average of 346.71K.
- Price is -26.3% vs its 50-day average ($12.95) and -45.9% vs its 200-day average ($17.65).
- 52-week range $9.36–$26.18; today's close sits at 1% of that range, 63.5% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — DBVT dips 2.1% to $9.77, a 52-week low, 5 down days in a row
- Closed at $9.77, -2.10% vs the prior close of $9.98. Day range $9.64–$10.05, opened at $9.74.
- Volume was 535.30K shares, 1.6x its 50-day average of 343.33K.
- Price is -25.1% vs its 50-day average ($13.04) and -44.8% vs its 200-day average ($17.71).
- 52-week range $9.64–$26.18; today's close sits at 1% of that range, 62.7% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — DBVT slides 4.4% to $9.98, a 52-week low, 4 down days in a row
- Closed at $9.98, -4.41% vs the prior close of $10.44. Day range $9.82–$10.66, opened at $10.64.
- Volume was 558.00K shares, 1.6x its 50-day average of 339.78K.
- Price is -23.9% vs its 50-day average ($13.11) and -43.8% vs its 200-day average ($17.77).
- 52-week range $9.82–$26.18; today's close sits at 1% of that range, 61.9% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — DBVT dips 1.0% to $10.44, a 52-week low, 3 down days in a row
- Closed at $10.44, -1.04% vs the prior close of $10.55. Day range $10.23–$10.74, opened at $10.35.
- Volume was 224.50K shares, 0.7x its 50-day average of 339.11K.
- Price is -20.9% vs its 50-day average ($13.19) and -41.5% vs its 200-day average ($17.83).
- 52-week range $10.23–$26.18; today's close sits at 1% of that range, 60.1% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — DBVT slides 5.9% to $10.55, a 6-month low on 2.1x normal volume
- Closed at $10.55, -5.89% vs the prior close of $11.21. Day range $10.47–$11.01, opened at $10.92.
- Volume was 673.30K shares, 2.1x its 50-day average of 327.68K — unusually heavy trading.
- Price is -20.4% vs its 50-day average ($13.25) and -41.0% vs its 200-day average ($17.87).
- 52-week range $10.47–$26.18; today's close sits at 1% of that range, 59.7% below the 52-week high.
DBVT latest news & SEC filings
Every SEC filing by or about DBVT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 31, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mohideen Pharis sold 464 shares at $2.70 (≈$1.25K) on Jul 29, 2026
- Mohideen Pharis sold 464 shares at $2.70 (≈$1.25K) on Jul 29, 2026
- Mohideen Pharis sold 464 shares at $2.70 (≈$1.25K) on Jul 29, 2026
- Mohideen Pharis sold 464 shares at $2.70 (≈$1.25K) on Jul 29, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 27, 2026 · Form S-3ASR — S-3ASR filing
S-3ASR filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 16, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $700.00K (prior year $1.50M) (-53.3% vs Jun 30, 2025)
- Net income: -$50.40M (prior year -$41.90M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.12 (prior year -$0.31) (loss narrowed vs Jun 30, 2025)
Jun 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade DBVT
- Last results release: Jul 16, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Mar 26, 2026, Oct 29, 2025. Based on that rhythm, the next report is likely around Oct 15, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.72% (largest 5.9%).
- Liquidity: about 412.15K shares (≈$3.73M) trade per day on average.
- 52-week position: $9.05 vs a range of $8.63–$26.18 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Pharis Mohideen sold 464 shares on Jul 29, 2026.
- Latest filings: 8-K Sep 30, 2026; 8-K Jul 16, 2026; 10-Q Jul 16, 2026.
- Share count: 296.06M shares outstanding (Jul 16, 2026), +116.1% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
DBVT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9.02 | 9.13 | 8.63 | 9.05 | 592.92K |
| Oct 15, 2026 | 8.87 | 9.20 | 8.85 | 9.11 | 432.30K |
| Oct 14, 2026 | 9.09 | 9.11 | 8.86 | 8.87 | 351.20K |
| Oct 13, 2026 | 9.47 | 9.50 | 8.90 | 9.03 | 344.10K |
| Oct 12, 2026 | 9.63 | 9.72 | 9.39 | 9.55 | 311.80K |
| Oct 9, 2026 | 9.62 | 9.86 | 9.43 | 9.80 | 324.00K |
| Oct 8, 2026 | 9.74 | 9.84 | 9.36 | 9.55 | 603.30K |
| Oct 7, 2026 | 9.74 | 10.05 | 9.64 | 9.77 | 535.30K |
| Oct 6, 2026 | 10.64 | 10.66 | 9.82 | 9.98 | 558.00K |
| Oct 5, 2026 | 10.35 | 10.74 | 10.23 | 10.44 | 224.50K |
| Oct 2, 2026 | 10.92 | 11.01 | 10.47 | 10.55 | 673.30K |
| Oct 1, 2026 | 11.30 | 11.58 | 11.02 | 11.21 | 564.50K |
| Sep 30, 2026 | 11.72 | 12.21 | 11.72 | 11.76 | 401.00K |
| Sep 29, 2026 | 11.50 | 11.68 | 11.40 | 11.55 | 199.50K |
| Sep 28, 2026 | 11.56 | 12.13 | 11.53 | 11.64 | 712.90K |
| Sep 25, 2026 | 11.40 | 11.83 | 11.40 | 11.56 | 290.00K |
| Sep 24, 2026 | 11.95 | 12.12 | 11.27 | 11.60 | 333.50K |
| Sep 23, 2026 | 12.46 | 12.63 | 12.10 | 12.17 | 377.50K |
| Sep 22, 2026 | 12.03 | 12.73 | 11.93 | 12.63 | 282.00K |
| Sep 21, 2026 | 12.31 | 12.31 | 12.00 | 12.10 | 131.40K |
About DBV Technologies
DBV Technologies (DBVT) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in CHATILLON. State of incorporation: France. Fiscal year ends December 31. SEC CIK 1613780.
DBVT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| L.P. 667, | Director | Jan 14, 2026 |
| Bros. Advisors Lp Baker | Director | Jan 14, 2026 |
| Felix Baker | Director | Jan 14, 2026 |
| Julian Baker | Director | Jan 14, 2026 |
| Bros. Advisors (Gp) Llc Baker | Director | Jan 14, 2026 |
| Brothers Life Sciences Lp Baker | Director | Jan 14, 2026 |
| Philina Lee | Director | Apr 16, 2026 |
| Daniel Tasse | CHIEF EXECUTIVE OFFICER | Nov 24, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Virginie Boucinha | Chief Financial Officer | Nov 24, 2025 |
| Pharis Mohideen | Chief Medical Officer | Jul 31, 2026 |
| Daniel Tasse | CHIEF EXECUTIVE OFFICER | Nov 24, 2025 |
| Kevin Michael Trapp | Chief Commercial Officer | Nov 24, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 29, 2026 | Pharis Mohideen | Sale | 464 | $2.70 |
| Jul 29, 2026 | Pharis Mohideen | Sale | 464 | $2.70 |
| Jul 29, 2026 | Pharis Mohideen | Sale | 464 | $2.70 |
| Jul 29, 2026 | Pharis Mohideen | Sale | 464 | $2.70 |
| Jan 29, 2026 | Pharis Mohideen | Sale | 534 | $4.86 |
| Jan 29, 2026 | Pharis Mohideen | Sale | 534 | $4.86 |
| Jan 29, 2026 | Pharis Mohideen | Sale | 534 | $4.86 |
| Jan 29, 2026 | Pharis Mohideen | Sale | 534 | $4.86 |
| Dec 18, 2025 | Bpifrance Epic | Sale | 1,292,103 | $4.19 |
| Dec 18, 2025 | Bpifrance Epic | Sale | 1,292,103 | $4.19 |
| Dec 18, 2025 | Investissement S.A.S. Bpifrance | Sale | 1,292,103 | $4.19 |
| Dec 18, 2025 | Investissement S.A.S. Bpifrance | Sale | 1,292,103 | $4.19 |
| Dec 18, 2025 | Participations Sa Bpifrance | Sale | 1,292,103 | $4.19 |
| Dec 18, 2025 | Participations Sa Bpifrance | Sale | 1,292,103 | $4.19 |
| Dec 18, 2025 | Sa Bpifrance | Sale | 1,292,103 | $4.19 |
DBVT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $5.64M | $-146.95M | -1.05 | $-121.18M |
| Dec 31, 2024 | $4.15M | $-113.92M | -1.17 | $-104.47M |
| Dec 31, 2023 | $15.73M | $-72.73M | -0.76 | $-79.65M |
| Dec 31, 2022 | $4.84M | $-96.27M | -1.24 | $-55.67M |
| Dec 31, 2021 | $5.71M | $-97.81M | -1.78 | $-108.24M |
Latest balance sheet: total assets $223.20M, total liabilities $62.80M, cash $174.90M (as of Jun 30, 2026).
DBVT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 16, 2026 | 8-K Item 2.02 (results) | $14.86 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $21.00 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $20.21 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $15.21 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $9.80 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $9.01 |
| Mar 24, 2025 | 8-K Item 2.02 (results) | $4.46 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $0.77 |
| Oct 22, 2024 | 8-K Item 2.02 (results) | $0.70 |
| Jul 30, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 7, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on DBVT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.